Alder Biopharmaceuticals Inc.

Leaving past limitations behind, Danish pharma widens its technology aperture to brain shuttles, AI and more  

Danish pharma eyeing growth beyond loss of exclusivity for Rexulti, aiming for broad label in rare epilepsies

Plus: Albers joins Atlas, new CBO at Altimmune and updates from Nuvig, Zymeworks, Fulcrum, Step, Charm, Kymera and more

Dunsire era brings new blood to R&D, appetite for risk, and open doors for partnering

Korea Biotechnology Industry Organization appointed Christopher Hansung Ko as the new president of the trade group. Ko is the CEO of biosimilars company Samsung Bioepis Co. Ltd. Immune medicine

Zai Lab Ltd. (NASDAQ:ZLAB; HKEX:9688) hired Alan Sandler as president, head of global development, oncology, a newly created position. Sandler was SVP and global head of product development oncology

It’s been a busy week for C4 Therapeutics Inc., which hired a new CEO and filed to go public. Andrew Hirsch is joining the protein degradation company from Agios

With little difference in efficacy or price, the CGRP competition will boil down to delivery, frequency and access

Neurology is back, as buysiders home in on 2020 opportunities